Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 19

1.

Insulin-like growth factor binding protein 2 (IGFBP-2) promotes growth and survival of breast epithelial cells: novel regulation of the estrogen receptor.

Foulstone EJ, Zeng L, Perks CM, Holly JM.

Endocrinology. 2013 May;154(5):1780-93. doi: 10.1210/en.2012-1970. Epub 2013 Mar 20.

PMID:
23515291
2.

IGFBP-3 can either inhibit or enhance EGF-mediated growth of breast epithelial cells dependent upon the presence of fibronectin.

McIntosh J, Dennison G, Holly JM, Jarrett C, Frankow A, Foulstone EJ, Winters ZE, Perks CM.

J Biol Chem. 2010 Dec 10;285(50):38788-800. doi: 10.1074/jbc.M110.177311. Epub 2010 Sep 17.

3.

Hyperglycaemia confers resistance to chemotherapy on breast cancer cells: the role of fatty acid synthase.

Zeng L, Biernacka KM, Holly JM, Jarrett C, Morrison AA, Morgan A, Winters ZE, Foulstone EJ, Shield JP, Perks CM.

Endocr Relat Cancer. 2010 May 18;17(2):539-51. doi: 10.1677/ERC-09-0221. Print 2010 Jun.

PMID:
20356977
4.

How growth hormone may be linked to cancer: concerns and perspective.

Holly JM, Foulstone EJ, Perks CM.

Expert Rev Endocrinol Metab. 2007 Nov;2(6):759-771. doi: 10.1586/17446651.2.6.759.

PMID:
30290467
5.

Structural insights into the interaction of insulin-like growth factor 2 with IGF2R domain 11.

Williams C, Rezgui D, Prince SN, Zaccheo OJ, Foulstone EJ, Forbes BE, Norton RS, Crosby J, Hassan AB, Crump MP.

Structure. 2007 Sep;15(9):1065-78.

6.
7.

Soluble IGF2 receptor rescues Apc(Min/+) intestinal adenoma progression induced by Igf2 loss of imprinting.

Harper J, Burns JL, Foulstone EJ, Pignatelli M, Zaina S, Hassan AB.

Cancer Res. 2006 Feb 15;66(4):1940-8.

8.
9.

Adaptations of the IGF system during malignancy: human skeletal muscle versus the systemic environment.

Foulstone EJ, Savage PB, Crown AL, Holly JM, Stewart CE.

Horm Metab Res. 2003 Nov-Dec;35(11-12):667-74.

PMID:
14710345
10.

Role of insulin-like growth factor binding protein-3 (IGFBP-3) in the differentiation of primary human adult skeletal myoblasts.

Foulstone EJ, Savage PB, Crown AL, Holly JM, Stewart CE.

J Cell Physiol. 2003 Apr;195(1):70-9.

PMID:
12599210
11.

Insulin-like growth factors (IGF-I and IGF-II) inhibit C2 skeletal myoblast differentiation and enhance TNF alpha-induced apoptosis.

Foulstone EJ, Meadows KA, Holly JM, Stewart CE.

J Cell Physiol. 2001 Nov;189(2):207-15.

PMID:
11598906
12.

Confocal imaging of the subcellular distribution of phosphatidylinositol 3,4,5-trisphosphate in insulin- and PDGF-stimulated 3T3-L1 adipocytes.

Oatey PB, Venkateswarlu K, Williams AG, Fletcher LM, Foulstone EJ, Cullen PJ, Tavaré JM.

Biochem J. 1999 Dec 1;344 Pt 2:511-8.

14.

Regulation of initiation factor eIF-2B by GSK-3 regulated phosphorylation.

Welsh GI, Loughlin AJ, Foulstone EJ, Price NT, Proud CG.

Biochem Soc Trans. 1997 May;25(2):191S. No abstract available.

PMID:
9191235
16.
17.
18.

Multiple signalling pathways involved in the stimulation of fatty acid and glycogen synthesis by insulin in rat epididymal fat cells.

Moule SK, Edgell NJ, Welsh GI, Diggle TA, Foulstone EJ, Heesom KJ, Proud CG, Denton RM.

Biochem J. 1995 Oct 15;311 ( Pt 2):595-601.

19.

Supplemental Content

Loading ...
Support Center